£89.00

Norway's Pharmaceutical Revolution: Pursuing and Accomplishing Innovation in Nyegaard & Co., 1945-1997

Business & Economic History

Price data last checked 155 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Same price for 5 weeks. Today is much like next week.

£89 for 33 days straight · last change was Dec 2025

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 576 days • 576 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 576 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £81-91 (341 days, 59.2%)

Price range: £44 - £91

Price levels: 4 price ranges over 576 days

Description

The pharmaceutical revolution that gathered pace in the 1930s delivered a plethora of almost magical new drugs such as penicillin, streptomycin, cortisone, and the birth control pill. This revolution grew from academic-business relationships in five countries: USA, Germany, Great Britain, Switzerland, and France. Many other countries tried and failed to replicate this success, yet a handful of Scandinavia companies made important breakthroughs in a narrow band of specialities. This is the story of how one Norwegian company-- Nyegaard & Co. --achieved international success from the 1970s onwards with a breakthrough product facilitating X-ray pictures of the soft tissues of the body. The company succeeded by harnessing research skills and creating scientific and business alliances abroad, building its own momentum step by step: the corporation as entrepreneur. It thereby broke with the conventional way a national medical ecosystem facilitated the crucial scientific progress. This is a story both of personal initiatives and great organizational transformations in several stages. In the 1950s, Nyegaard & Co. was a small hierarchical home market-oriented generics company. By the end of the 1990s, it had developed into a fairly large and multinational hierarchical company, preoccupied as much with shareholder value as scientific progress. It has also become a company that no longer had the same ability to innovate as before and therefore became merged into another one.

Product Specifications

Format: hardcover
ASIN: 0192869000
Category: Books > Subjects > Business, Finance & Law > Biographies & Histories > Business & Economic History
Domain: Amazon UK
Release Date: 15 September 2022
Listed Since: 19 May 2022

Barcode

No barcode data available

Norway's Pharmaceutical Revolution: Pursuing and Accomplishing Innovation in Nyegaard & Co., 1945-1997

Same price for 5 weeks. Today is much like next week.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

World Pharmaceutical Industry

Dorosz guide pratique des medicaments 2023, 42e ed

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2011, Volume 1263 (Annals of the New York Academy of Sciences)

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

The 2007 Import and Export Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives in United States

dorosz guide pratique des medicaments 2021, 40e ed

Dorosz Guide pratique des médicaments 2025, 44e éd.

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Medicating Modern America: Prescription Drugs in History

That High Design of Purest Gold: A Critical History of the Pharmaceutical Industry, 1880–2020

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

World Scientific - That High Design of Purest Gold Book

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010, Volume 1222: 77 (Annals of the New York Academy of Sciences)

The 2023 Report on E-Pharma: World Market Segmentation by City

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan

Global Issues in Pharmaceutical Marketing

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Government, Big Pharma, and The People: A Century of Dis-Ease

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

The 2023 Report on Pharma Contract Sales: World Market Segmentation by City

Springer - Innovation and Marketing in Pharmaceutical Industry

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health